Spots Global Cancer Trial Database for reqorsa
Every month we try and update this database with for reqorsa cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib | NCT04486833 | Carcinoma, Non-... | quaratusugene o... osimertinib Platinum-Based ... | 18 Years - | Genprex, Inc. | |
Quaratusugene Ozeplasmid (Reqorsa) in Combination With Pembrolizumab in Previously Treated Non-Small Lung Cancer | NCT05062980 | Non Small Cell ... | quaratusugene o... pembrolizumab docetaxel ramucirumab Investigator's ... | 18 Years - | Genprex, Inc. | |
Quaratusugene Ozeplasmid (Reqorsa) in Combination With Pembrolizumab in Previously Treated Non-Small Lung Cancer | NCT05062980 | Non Small Cell ... | quaratusugene o... pembrolizumab docetaxel ramucirumab Investigator's ... | 18 Years - | Genprex, Inc. | |
Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients | NCT05703971 | Small Cell Lung... | quaratusugene o... atezolizumab | 18 Years - | Genprex, Inc. | |
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib | NCT04486833 | Carcinoma, Non-... | quaratusugene o... osimertinib Platinum-Based ... | 18 Years - | Genprex, Inc. |